Loading stock data…
UFP Technologies, Inc. (UFPT)
$281.21-7.58 (-2.62%)
Market ClosedLast close Sep 8
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
UFP Technologies, Inc. in the Healthcare sector is trading at $281.21 with a market capitalization of $2.5B. Wall Street consensus targets $355.00 (2 analysts), implying a +26.2% move over the next 12 months. The stock is currently 17% below its 52-week high of $338.71, remaining 18.3% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 16 is oversold, raising the odds of a near-term bounce. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +26.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 16) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $173.96M↑ | $154.20M↑ | $148.91M↓ | $154.56M↑ | $151.18M |
| Gross Profit | $50.92M↑ | $44.36M↑ | $41.97M↓ | $42.75M↓ | $43.54M |
| Operating Income | $28.16M↑ | $23.34M↑ | $21.00M↓ | $23.68M↓ | $24.86M |
| Net Income | $20.85M↑ | $17.50M↓ | $17.57M↑ | $16.38M↓ | $17.18M |
Peer Comparison
JNJUNHPFE
Fundamentals
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.51B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
35.08
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.06
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
11.72%
Volume
Today's trading volume
115,404
Recent News
UFP Technologies (UFPT) Posts Record Profits, But The Margin Story Gets Complicated
On August 3, UFP Technologies (NASDAQ:UFPT) reported second-quarter net income of $20.9 million, up 21.4% from $17.2 million a year earlier, alongside net sales of $174.0 million, a 15.1% jump from $151.2 million. Both figures, along with adjusted earnings per share of $2.92, marked the best quarter in the company’s history. For the six months […]
UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares
Feldmann reduced her direct stake by 18%.
UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds
UFP Technologies (NASDAQ:UFPT) outlined its strategy to expand through organic growth and acquisitions, emphasizing its role as a contract development and manufacturing organization serving medical-device companies. President and Chief Executive Officer Mitch Rock said the company provides engineer
2 Profitable Stocks with Exciting Potential and 1 Facing Headwinds
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
The Top 5 Analyst Questions From UFP Technologies’s Q2 Earnings Call
UFP Technologies delivered a calendar second quarter marked by strong, broad-based growth across its MedTech platform, which exceeded Wall Street’s revenue and profit expectations. Management pointed to robust performance in key submarkets such as cardiovascular, infection control, and orthopedics, as well as continued diversification across customer programs. CEO Mitchell Rock, in his first earnings call as chief executive, emphasized that growth this quarter was not tied to any one customer or